Yousef Badran (@YRBadran) profile picture

Biotech investing and company building, physician-scientist @MGH, co-founder @heliosforyou

Boston,MA
Joined March 2011
Photo by Yousef Badran (@YRBadran)Photo by Yousef Badran (@YRBadran)Photo by Yousef Badran (@YRBadran)Photo by Yousef Badran (@YRBadran)Photo by Yousef Badran (@YRBadran)Photo by Yousef Badran (@YRBadran)Photo by Yousef Badran (@YRBadran)Photo by Yousef Badran (@YRBadran)Photo by Yousef Badran (@YRBadran)Photo by Yousef Badran (@YRBadran)
Yousef Badran retweeted
Hello, world. Your blood has a lot to say. 🩸
Introducing Helios: measuring 1,000+ protein biomarkers from a drop of blood to help you live younger, longer. Here’s how it works: • Self-collect blood at home with a painless, needle-free device • We measure the proteins carrying signals from cells and organs throughout your body • Your Helios AI agent explains your results, highlights risks, and offers personalized guidance Proudly backed by Y Combinator and Formation VC. Join the waitlist at myhelios.com
5
5
1
27
1,877
Yousef Badran retweeted
Something I've been excited about for a long time--how we can create a way for everybody to get the clearest picture of their health, from the comfort of their own home. @omarabudayyeh, @YRBadran, and I have been hard at work translating proteomics to be accessible to everybody. An incredible amount of research indicates that proteins are the best way to model the future of human health (although I think combining them with other data is even better...watch this space!) I believe that @heliosforyou will be the way that we can all track our bodies, pushing back disease and letting us live younger, longer. Also, thanks @AmyDMarcus and @theinformation for covering our story!
Introducing Helios: measuring 1,000+ protein biomarkers from a drop of blood to help you live younger, longer. Here’s how it works: • Self-collect blood at home with a painless, needle-free device • We measure the proteins carrying signals from cells and organs throughout your body • Your Helios AI agent explains your results, highlights risks, and offers personalized guidance Proudly backed by Y Combinator and Formation VC. Join the waitlist at myhelios.com
10
15
2
83
4,836
1/ What do peptides, supplements and “longevity stacks” actually change in the body? Plasma proteomics gives us a way to look. By measuring thousands of proteins over time, we can see what shifts and use those signals to guide what we study next.
Introducing Helios: measuring 1,000+ protein biomarkers from a drop of blood to help you live younger, longer. Here’s how it works: • Self-collect blood at home with a painless, needle-free device • We measure the proteins carrying signals from cells and organs throughout your body • Your Helios AI agent explains your results, highlights risks, and offers personalized guidance Proudly backed by Y Combinator and Formation VC. Join the waitlist at myhelios.com
2
6
18
4,688
5/ For patients, years of research in large cohorts suggest that patterns in blood proteins could help estimate disease risk before symptoms appear. I’m excited that Helios is building the next generation of disease prediction tools to help patients understand their risk earlier.
1
120
6/ Excited to co-found @heliosforyou with my good friends @jgooten and @omarabudayyeh
1
2
121
4/ A protein shift is a clue about what’s changing in the body. It can help us prioritize which interventions to test for health benefits in proper trials.
1
13
5/ Years of research in large cohorts suggest that patterns in blood proteins could help estimate disease risk before symptoms appear. I’m excited that we’re building the next generation of disease prediction tools to help patients understand their risk earlier. Excited to co-found @heliosforyou with my good friends @jgooten and @omarabudayyeh.
1
25
General Medicine is right, this is the future of healthcare. The current model is clearly falling short for patients, and meaningful disruption is long overdue. It’s time to rethink how care is delivered and build a system that truly puts patients first. Congratulations @tjparker @elliotcohen @ashwinkmurali
General Medicine has raised a $120M Series B led by @a16z. We're using it to build the healthcare store. The only way healthcare will work is to make the customer the most powerful participant in the system. And the only way to do that is to let them shop. Here’s why healthcare needs a store, and what we had to build to make it possible:
1
3
573
After the IL-6 and Lp(a) data, a key question is: how do we define residual risk? Does it mean risk despite optimal therapy in trial-motivated, statin-adherent patients and if so, at what LDL-C threshold?
1
1
3
2,784
The incremental benefit of lowering Lp(a) on top of LDL-C was first inferred from PCSK9 outcomes trials. This study now provides genetic validation, and further supports the therapeutic thesis for dual targeting of Lp(a) and LDL-C. Congratulations to @aklfahed and team. nature.com/articles/s44161-0…
1
8
1,372
1/ Reflecting today with the MGH @mghmedres physician-scientist training program on biotech venture investing and company formation, I realized there’s a rare archetype of “KOLs” I’ve encountered after hundreds of conversations across therapeutic areas.
1
2
30
14,877
5/ They don’t replace your judgment. They make your judgment better. The best ones also ask the hardest questions and those conversations are often the most enjoyable. You are luckiest if they are your friends!
1
2
194
Thank you @chivukula_raghu, Marc Wein, and Jay Rajagopal for the invite.
3
188